Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about ANI Pharmaceuticals, Inc. - Convertible Offering - B240901
$316.2 Million
Image
Convertible Offering
Active Bookrunner
Read more
about The Woodlands Financial Group - IPO - B230455 - 2024/07/17
$187.0 Million
Image
The Woodlands Financial Group
Initial Public Offering
Active Bookrunner
Read more
about Angel Oak Mortgage REIT, Inc. - Senior Notes - B240718 - 2024/07/18
$50.0 Million
Image
Angel Oak Mortgage REIT, Inc.
Senior Notes Offering
Active Bookrunner
Read more
about Nurix Inc. - CMFO - B240340 - 2024/04/11
$201.2 Million
Image
Nurix Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Biohaven Ltd. - CMFO - B240400 - 2024/04/17
$264.5 Million
Image
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Sound Point Meridian Capital, Inc. - IPO - B240568 - 2024/06/13
$80.0 Million
Image
Sound Point Meridian Capital, Inc.
Initial Public Offering
Active Bookrunner
Read more
about Tourmaline Bio - CMFO - B231831 - 2024/01/25
$172.4 Million
Image
Tourmaline Bio
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Mr. Cooper Group Inc. - Senior Notes - B240068 - 2024/01/29
$1.0 Billion
Image
Mr. Cooper Group Inc.
Senior Notes
Active Bookrunner
Read more
about New Amsterdam Pharma N.V. - CMFO - B231795 - 2024/02/13
$201.5 Million
Image
New Amsterdam Pharma N.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Aquestive Therapeutics, Inc. - CMFO - B240238 - 2024/03/19
$75.0 Million
Image
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Page 1
Next page
››
Subscribe to Active Bookrunner